CAS: 915769-50-5
Molecular Formula: C24H29FN6O5
Molecular weight:500.5227
Appearance:white powder
Stability:Stable
Shelf life:2 years
Product description :Dovitinib is a benzimidazole-quinolinone compound and receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Dovitinib binds to and inhibits the phosphorylation of type III-V RTKs, such as vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) that promote tumor cell proliferation and survival in certain cancer cells.